Hemoglobin as a Treatable Trait in COPD: A Retrospective Observational Cohort Study on Hemoglobin Levels and All-Cause Mortality from NHANES Data
International Journal of Chronic Obstructive Pulmonary Disease · 2025
DOI: 10.2147/copd.s537888 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2025. Verfasst von Dongxiang Ji und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University, Huzhou, People's Republic of China. Hauptthemen laut MEDLINE: Anemia, Hemoglobins, Pulmonary Disease, Chronic Obstructive. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: COPD
Abstract (Originalsprache)
Background
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally. Hemoglobin (HGB) abnormalities, including anemia and secondary polycythemia, are common comorbidities in COPD patients, yet their association with mortality remains less clear. This study aimed to investigate the relationship between HGB levels and all-cause mortality in COPD patients and to evaluate whether HGB could serve as a treatable trait in COPD.
Methods
We conducted a retrospective observational cohort study using data from the National Health and Nutrition Examination Survey (NHANES, 2013-2018). A total of 544 COPD patients were included. Multivariable Cox regression was conducted to assess HGB-mortality associations, adjusting for age, sex, BMI, smoking status, and comorbidities. Nonlinear relationships were examined using generalized additive models with threshold effect analysis. Stratified analyses were performed by sex, age, and comorbidity status.
Results
Among 544 COPD patients, HGB levels demonstrated a significant nonlinear association with all-cause mortality, with a critical inflection point identified at 14.2 g/dL. Below this threshold, each 1g/dL in HGB was associated with reduced mortality (adjusted HR=0.73, 95% CI: 0.61-0.79, P 65 years, smokers, and those with cardiovascular disease), interaction tests did not reach statistical significance (all P-interaction >0.05), indicating no evidence of effect modification. Smoothing curves supported this nonlinear relationship, showing decreasing mortality risk with rising HGB until the threshold, beyond which risk stabilized with a slight non-significant upward trend.
Conclusion
This study identifies a nonlinear relationship between HGB levels and mortality in COPD, establishing 14.2 g/dL as a critical threshold that supports anemia's inclusion in the COPD "treatable traits" framework. Below this value, increasing HGB is associated with reduced mortality, whereas above it no further benefit is observed. Clinicians should prioritize HGB monitoring in high-risk subgroups (elderly males, smokers, and cardiac comorbidities).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University, Huzhou, People's Republic of China.
- Department of Otorhinolaryngology, Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University, Huzhou, People's Republic of China.
Zitieren
APA
Ji, D., & Yu, H. (2025). Hemoglobin as a Treatable Trait in COPD: A Retrospective Observational Cohort Study on Hemoglobin Levels and All-Cause Mortality from NHANES Data. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s537888
Vancouver
Ji D, Yu H. Hemoglobin as a Treatable Trait in COPD: A Retrospective Observational Cohort Study on Hemoglobin Levels and All-Cause Mortality from NHANES Data. International Journal of Chronic Obstructive Pulmonary Disease. 2025. doi:10.2147/copd.s537888
BibTeX
@article{Ji2025,
author = {Ji, Dongxiang and Yu, Hewei},
title = {Hemoglobin as a Treatable Trait in COPD: A Retrospective Observational Cohort Study on Hemoglobin Levels and All-Cause Mortality from NHANES Data},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2025},
doi = {10.2147/copd.s537888}
}
EUVIMED